Dr Siddhartha Mukherjee’s book ‘The Song of the Cell’ highlights the promise of cell therapy
The latest book by Dr. Siddhartha Mukherjee, co-founder of Immunol Therapeutics, ‘The Song of the Cell: An Exploration of Medicine and the New Human’, provides an organized approach to understanding the workings of cells, which are made up of complex mechanisms. There are
Winner of the Pulitzer Prize, Guardian First Book Award winner and recipient of the 2014 Padma Shri, Dr Mukherjee said, “We are entering a new century of the cell. Today fundamental questions in biology and medicine are answered by cells and cell biology. Our new ability to manipulate cells and thereby change their properties is also opening new frontiers in medicine. I wrote this book because I felt it was necessary to bring these ideas to the public It needs to be brought down to a level that they can understand.”
“All diseases are cellular diseases and cellular therapies are a game-changer for cancer treatment. So the book brings out the essence of cell pathology and cell biology,” said Dr Mukherjee, who is also an assistant professor of medicine at Columbia University, during an engaging conversation with Kiran Mazumdar-Shaw, executive chairman, Biocon and Biocon Biologics . book launch.
Shedding new light on the evolving field of gene and cell therapy, a set of technologies that hold the promise of revolutionizing medicine through their potential to cure hitherto incurable diseases, the chat discusses the future and future of modern medicine. Also noted its transformative potential to help. Humanity enjoys long and healthy life.
Shaw said of that book, “The Song of the Cell is a priceless chronicle of how scientists discovered cells, how they began to understand cell biology and are now using that knowledge to initiate revolutionary changes through biomedicine.” doing for.” central pillar of science.
Shaw explained how the author has brought her experience as a scientist, a doctor, and an author to telling this fascinating story of cells, the basic structural and functional units of every living organism.
“The book delves deep into the mysteries of cellular science. It also inspires the reader to look forward to a better future as a greater understanding of cellular science is helping to uncover the diseases that still plague us and our ability to treat them. I believe it should be a prescribed textbook in every high school,” Shaw said.
Shaw and Dr. Mukherjee both co-founded Bengaluru-based Immunol Therapeutics, a clinical stage start-up working on personalized immunotherapies such as CAR-T therapy for cancer patients, at a time when India is facing a growing number of such cases. is seeing a dramatic increase in
These treatments are available at US$ 350K+ per dose. Immunal is looking for affordable access with its research.
“We are entering a new era of disruption in therapeutics with genomics, CRISPR-mRNA transforming cancer treatment,” said Dr. Mukherjee.
Source – pharmabiz